ESCO Announces Record Fourth Quarter and Fiscal 2022 Results

Rhea-AI Summary

ESCO Technologies reported strong Q4 and FY 2022 results, with GAAP EPS at $1.19, a 53% increase year-over-year, and total FY sales rising 20% to $858 million. Q4 sales grew 25% to $256 million, driven by organic growth and acquisitions. Operating cash flow reached $135 million, and year-end backlog hit a record $695 million. The company anticipates FY 2023 sales growth of 6-8%, with Adjusted EPS projected to increase by 7.5-12%. A leadership transition is also underway as Bryan Sayler will assume the role of CEO in 2023.

Positive

• Q4 GAAP EPS up 53% to $1.19, beating prior year
• FY 2022 sales increased 20% to $858 million
• Record year-end backlog of $695 million
• Anticipated FY 2023 sales growth of 6-8% and Adjusted EPS increase of 7.5-12%

Negative

• Q4 entered orders decreased by $14 million (5%) to $245 million
• Interest expense expected to rise by $4.3 million in FY 2023

- Q4 GAAP EPS $1.19 / Adjusted EPS $1.21 - FY 2022 Sales increase 20% to $858 Million - $135 Million in Cash Flow from Operations in FY 2022 -

St. Louis, Nov. 17, 2022 (GLOBE NEWSWIRE) -- ESCO Technologies Inc. (NYSE: ESE) (ESCO, or the Company) today reported its operating results for the fourth quarter (Q4 2022) and fiscal year (FY 2022) ended September 30, 2022.

Operating Highlights

• Q4 2022 GAAP EPS increased $0.41 per share (53 percent) to $1.19 per share compared to $0.78 per share in Q4 2021.   Q4 2022 Adjusted EPS increased $0.36 per share (42 percent) to $1.21 per share compared to $0.85 per share in Q4 2021.
• FY 2022 GAAP EPS increased $0.74 per share (31 percent) to $3.16 per share compared to $2.42 per share in FY 2021. FY 2022 Adjusted EPS increased $0.62 per share (24 percent) to $3.21 per share compared to $2.59 per share in FY 2021.
• Q4 2022 sales increased $51 million (25 percent) to $256 million compared to $205 million in Q4 2021. Organic sales increased $38 million (19 percent) and recent acquisitions added $13 million (6 percent) of revenue growth in the quarter.
• FY 2022 sales increased $142 million (20 percent) to $858 million. Organic sales increased $90 million (13 percent) and recent acquisitions added $52 million (7 percent) of revenue growth for the full year.   
• Q4 2022 entered orders decreased $14 million (5 percent) compared to the prior year period to $245 million (book-to-bill of 0.95x). Full year 2022 entered orders increased $164 million (21 percent) to $961 million (book-to-bill of 1.12x) and resulted in record year-end backlog of $695 million.
• Net cash provided by operating activities was $94 million in Q4 and $135 million for the full year, resulting in an increase of $12 million (10 percent) over the prior year.  
• Net debt (total borrowings less cash on hand) was $55 million, resulting in a leverage ratio of 0.78x and $589 million in available liquidity on September 30, 2022.
  
  

FY 2022 was a record year for sales, Adjusted EBIT, Adjusted EPS, cash flow from operations, entered orders, and year-end backlog.   Entered orders were strong across our end-markets, with all three business segments reporting a book-to-bill greater than 1.1x.   Overall, entered orders increased 21 percent compared to the prior year and drove record year-end backlog of $695 million.   Cash flow from operations was $135 million with a 108 percent free cash flow conversion rate.   Recovery in key end-markets combined with solid orders momentum drove meaningful growth and improved operating results during the year.

Vic Richey, Chairman and Chief Executive Officer, commented, “Given the continuing economic disruptions and global headwinds throughout the year, I am very pleased that we were able to deliver outstanding results from both a growth and profitability perspective. Despite considerable challenges, we were able to exceed our commitments as communicated at the start of the year. ESCO is an industry leader that serves healthy end-markets, and through the tremendous efforts of our employees we were able to deliver results we are all very proud of in 2022.”

Segment Performance

Aerospace & Defense (A&D)

• Q4 2022 sales increased $24 million (30 percent) to $104 million from $80 million in Q4 2021. Q4 sales growth was the result of strong demand across our commercial and defense aerospace, Navy, and space platforms.   FY 2022 sales increased $37 million (12 percent) to $351 million, largely driven by commercial aerospace, which increased $30 million (32 percent) to $123 million. Higher Navy and space sales were partially offset by lower industrial sales compared to the prior year.
• Q4 2022 EBIT increased $8.7 million to $23.3 million from $14.6 million in Q4 2021. Adjusted EBIT increased $8.9 million in Q4 2022 to $23.6 million (22.7 percent margin) from $14.7 million (18.3 percent margin) in Q4 2021. FY 2022 EBIT increased $11.9 million to $68.4 million from $56.5 million in FY 2021. FY 2022 Adjusted EBIT increased $12.0 million to $69.0 million (19.6 percent margin) from $57.0 million (18.1 percent margin) in FY 2021. Margin increases for the quarter and year were driven by higher volumes and price increases, partially offset by inflationary pressures.  
• Entered Orders increased $9 million to $97 million in Q4 2022.   For the full year entered orders increased $55 million (16 percent) to $392 million (book-to-bill of 1.12). The orders strength was primarily driven by the continuing recovery of commercial aerospace and resulted in record year-end backlog of $408 million.
  
  

Utility Solutions Group (USG)

• Q4 sales increased $22 million (37 percent) to $83 million from $61 million in Q4 2021. Organic sales increased $12 million (21 percent) and recent acquisitions Phenix and Altanova contributed $10 million in revenue.   FY 2022 sales increased $75 million (37 percent) to $278 million from $203 million in FY 2021. Doble organic sales increased $20 million (12 percent), NRG sales increased $8 million (24 percent), and Phenix and Altanova added $47 million, The organic sales growth was driven by increased electric utility spending and strong demand across our renewables product lines.
• Q4 2022 EBIT increased $6.5 million to $19.8 million from $13.3 million in Q4 2021. Adjusted EBIT increased $4.9 million in Q4 2022 to $19.8 million (23.7 percent margin) from $14.9 million (24.3 percent margin) in Q4 2021. FY 2022 EBIT increased $16.7 million to $57.6 million from $40.9 million in FY 2021. FY 2022 Adjusted EBIT increased $15.7 million to $58.1 million (20.9 percent margin) from $42.4 million (20.9 percent margin) in FY 2021. Adjusted EBIT increases for the quarter and year were largely driven by higher volumes and price increases, partially offset by inflationary pressures, increased travel and conference costs.  
• Entered Orders decreased $8 million to $88 million in Q4 2022. Orders for the quarter were lower due to the timing of orders booked related to the backlog acquired with the Phenix and Altanova transactions in Q4 2021. For the full year entered orders increased $71 million to $315 million (book-to-bill of 1.13) and resulted in year-end backlog of $128 million. Orders strength was driven by contributions from Altanova and Phenix, increased electric utility spending and continuing growth in the demand for renewables.  
  
  

Test

• Q4 2022 sales increased $5 million (8 percent) to $69 million from $64 million in Q4 2021, primarily due to increased medical and industrial shielding and power filter demand.   FY 2022 sales increased $30 million (15 percent) to $228 million, driven by increased test and measurement projects, medical and industrial shielding, and power filter demand.
• Q4 2022 EBIT increased $1.9 million to $11.8 million (17.0 percent margin) from $9.9 million (15.3 percent margin) in Q4 2021. FY 2022 EBIT increased $5.0 million to $32.6 million (14.3 percent margin) from $27.6 million (14.0 percent margin) in FY 2021. The increase in profitability was driven by leverage on higher sales and price increases, partially offset by material cost and wage inflation.
• Entered Orders decreased $14 million to $59 million in Q4 2022. Orders were lower during the quarter primarily due to the timing of large power filter orders in Q4 2021. For the full year entered orders increased $38 million to $253 million (book-to-bill of 1.11) and resulted in record year-end backlog of $159 million. The orders strength was driven by medical shielding and global demand for test and measurement projects.
  
  

Share Repurchase Program
The Company did not repurchase any shares of stock during Q4 2022. During FY 2022 the Company repurchased approximately 257,500 shares for $20 million.

Dividend Payment
The next quarterly cash dividend of $0.08 per share will be paid on January 20, 2023 to stockholders of record on January 5, 2023.

2023 Annual Meeting
The 2023 Annual Meeting of the Company’s Shareholders will be held on February 3, 2023.

Business Outlook – FY 2023
Management expects continued growth in sales, Adjusted EBIT, and Adjusted EBITDA across each of the Company’s business segments in 2023.

Management’s expectations for growth in 2023 compared to 2022:

• Net sales are expected to grow 6 to 8 percent and be in the range of $910 to $930 million on a consolidated basis, with A&D growing 10 to 13 percent, USG growing 5 to 7 percent, and Test growing 3 to 5 percent.
• Adjusted EBIT is expected to increase approximately 10 to 15 percent with Adjusted EBIT margins increasing to 13.5 to 14.0 percent of sales.
• Adjusted EBITDA is expected to increase approximately 7 to 12 percent with Adjusted EBITDA margins increasing to 19.0 to 19.5 percent of sales.
• Interest expense is expected to increase approximately $4.3 million to over $9 million (due to higher interest rates) excluding the impact of any future acquisitions.
• The effective income tax rate is expected to be in the range of 22.5 to 23.5 percent in 2023.
• Management projects 2023 Adjusted EPS to increase 7.5 to 12 percent and be in the range of $3.45 to $3.60 per share. This projection reflects margin expansion on the anticipated sales growth, partially offset by increased interest expense.
• Management expects flat to slightly up Adjusted EPS of $0.46 - $0.52 in Q1 2023 compared to the prior year. Consistent with prior years, revenues and Adjusted EPS are expected to grow sequentially throughout the year.
  
  

Management Transition
As previously announced, Vic Richey will be retiring from his roles as CEO and President at the end of the calendar year. Mr. Richey will continue as Executive Chairman of the Board during a transition period as current USG President Bryan Sayler assumes the roles of ESCO CEO and President. Richey commented “It’s been a pleasure to work at ESCO for 37 years and an honor to serve as CEO for the past 20 years. We have accomplished a lot during this time, and I am very thankful to our employees who have shown extreme dedication and effort over the years. I’d also like to thank our Board of Directors for their ongoing support of the Company as we worked to create what ESCO is today. I’m very excited about the future of the Company. Bryan has over 25 years of leadership experience at ESCO and is uniquely qualified to lead the company moving forward.” Mr. Sayler is currently transitioning from his position as President of the USG segment and will assume the positions of CEO and President of ESCO on January 1, 2023. “As I step into my new role at ESCO, I’m excited for the opportunity to lead this vibrant organization as we continue to build upon the strong foundation established under Vic’s leadership,” said Sayler.

Conference Call
The Company will host a conference call today, November 17, at 4:00 p.m. Central Time, to discuss the Company’s Q4 and full year 2022 results. A live audio webcast and an accompanying slide presentation will be available on ESCO’s investor website at https://investor.escotechnologies.com. For those unable to participate, a webcast replay will be available after the call on ESCO’s investor website.

Forward-Looking Statements
Statements in this press release regarding the timing and magnitude of recovery in the Company’s end markets, the continuing impacts of COVID-19 on the Company’s results, sales, Adjusted EBIT, Adjusted EBITDA, Adjusted EPS, cash flow, results of cost reduction efforts, margins, growth, the financial success of the Company, the strength of its end markets, the outlook for the A&D, Test and USG segments, the ability to increase shareholder value, the timing and success of acquisition efforts, internal investments in new products and solutions, the impacts of inflation, the long-term success of the Company, and any other statements which are not strictly historical are “forward-looking” statements within the meaning of the safe harbor provisions of the federal securities laws.

Investors are cautioned that such statements are only predictions and speak only as of the date of this release, and the Company undertakes no duty to update them except as may be required by applicable laws or regulations. The Company’s actual results in the future may differ materially from those projected in the forward-looking statements due to risks and uncertainties that exist in the Company’s operations and business environment including but not limited to those described in Item 1A, “Risk Factors”, of the Company’s Annual Report on Form 10-K for the fiscal year ended September 30, 2021; the availability and acceptance of viable COVID-19 vaccines by enough of the U.S. and world’s population to curtail the pandemic; the continuing impact of the COVID-19 pandemic and the effects of known or unknown COVID-19 variants including labor shortages, facility closures, shelter in place policies or quarantines, material shortages, transportation delays, termination or delays of Company contracts, and the inability of our suppliers or customers to perform; the impacts of Executive Order 14042 and other vaccine mandates on our employees and businesses; the impacts of natural disasters on the Company’s operations and those of the Company’s customers and suppliers; the timing and content of future contract awards or customer orders; the appropriation, allocation and availability of Government funds; the termination for convenience of Government and other customer contracts or orders; weakening of economic conditions in served markets; the success of the Company’s competitors; changes in customer demands or customer insolvencies; competition; intellectual property rights; technical difficulties; the success of the Company’s acquisition efforts; delivery delays or defaults by customers; performance issues with key customers, suppliers and subcontractors; changes in the costs and availability of certain raw materials; labor disputes; changes in U.S. tax laws and regulations; other changes in laws and regulations including but not limited to changes in accounting standards and foreign taxation; changes in interest rates; costs relating to environmental matters arising from current or former facilities; uncertainty regarding the ultimate resolution of current disputes, claims, litigation or arbitration; and the integration of recently acquired businesses.

Non-GAAP Financial Measures
The financial measures EBIT, Adjusted EBIT, EBITDA, Adjusted EBITDA, and Adjusted EPS are presented in this press release. The Company defines “EBIT” as earnings before interest and taxes, “EBITDA” as earnings before interest, taxes, depreciation and amortization, “Adjusted EBIT” and “Adjusted EBITDA” as excluding the net impact of the items described in the attached Reconciliation of Non-GAAP Financials Measures, and “Adjusted EPS” as GAAP earnings per share excluding the net impact of the items described and reconciled in the attached Reconciliation of Non-GAAP Financial Measures.

EBIT, Adjusted EBIT, EBITDA, Adjusted EBITDA, and Adjusted EPS are not recognized in accordance with U.S. generally accepted accounting principles (GAAP). However, Management believes EBIT, Adjusted EBIT, EBITDA, and Adjusted EBITDA are useful in assessing the operational profitability of the Company’s business segments because they exclude interest, taxes, depreciation, and amortization, which are generally accounted for across the entire Company on a consolidated basis. EBIT is also one of the measures used by Management in determining resource allocations within the Company as well as incentive compensation. The presentation of EBIT, Adjusted EBIT, EBITDA, Adjusted EBITDA, and Adjusted EPS provides important supplemental information to investors by facilitating comparisons with other companies, many of which use similar non-GAAP financial measures to supplement their GAAP results. The use of non-GAAP financial measures is not intended to replace any measures of performance determined in accordance with GAAP.

ESCO is a global provider of highly engineered products and solutions serving diverse end-markets. It manufactures filtration and fluid control products for the aviation, Navy, space, and process markets worldwide and composite-based products and solutions for Navy, defense, and industrial customers. ESCO is the industry leader in RF shielding and EMC test products; and provides diagnostic instruments, software and services to industrial power users and the electric utility and renewable energy industries. Headquartered in St. Louis, Missouri, ESCO and its subsidiaries have offices and manufacturing facilities worldwide. For more information on ESCO and its subsidiaries, visit the Company’s website at www.escotechnologies.com.
   

ESCO TECHNOLOGIES INC. AND SUBSIDIARIES
Condensed Consolidated Statements of Operations (Unaudited)
(Dollars in thousands, except per share amounts)
						Three Months Ended September 30, 2022			Three Months Ended September 30, 2021
Net Sales					$	256,498			205,478
Cost and Expenses:
		Cost of sales				154,323			128,260
		Selling, general and administrative expenses				53,054			44,906
		Amortization of intangible assets				6,553			6,100
		Interest expense				1,767			802
		Other (income) expenses, net				373			371
			Total costs and expenses			216,070			180,439
Earnings before income taxes						40,428			25,039
Income tax expense						9,388			4,674
			Net earnings		$	31,040			20,365
			Diluted EPS:
			Diluted - GAAP
				Net earnings	$	1.19			0.78
			Diluted - As Adjusted Basis
				Net earnings	$	1.21	(1	)	0.85	(2	)
			Diluted average common shares O/S:			25,990			26,232
(1	)	Q4 2022 Adjusted EPS excludes $0.02 per share of after-tax severance charges at VACCO and NRG and Corporate management transition costs.
(2	)	Q4 2021 Adjusted EPS excludes $0.07 per share of after-tax charges mainly consisting of purchase accounting adjustments related to the Phenix & Altanova acquisitions, acquisition costs at Corporate, and restructuring costs primarily within the USG segment.

   
   

ESCO TECHNOLOGIES INC. AND SUBSIDIARIES
Condensed Consolidated Statements of Operations (Unaudited)
(Dollars in thousands, except per share amounts)
						Year Ended September 30, 2022				Year Ended September 30, 2021
Net Sales					$	857,502				715,440
Cost and Expenses:
		Cost of sales				525,457				445,045
		Selling, general and administrative expenses				195,127				167,534
		Amortization of intangible assets				25,936				20,829
		Interest expense				4,851				2,255
		Other (income) expenses, net				(304	)			(894	)
			Total costs and expenses			751,067				634,769
Earnings before income taxes						106,435				80,671
Income tax expense						24,115				17,175
			Net earnings		$	82,320				63,496
			Diluted EPS:
			Diluted - GAAP
				Net earnings	$	3.16				2.42
			Diluted - As Adjusted Basis
				Net earnings	$	3.21		(1	)	2.59		(2	)
			Diluted average common shares O/S:			26,067				26,225
(1	)	FY 2022 Adjusted EPS excludes $0.05 per share of after-tax charges associated with the Altanova & Neco acquisition inventory step-up charges, severance charges at VACCO and NRG, Corporate acquisition costs and management transition costs.
(2	)	FY 2021 Adjusted EPS excludes $0.17 per share of after-tax charges mainly consisting of management transition and acquisition costs at Corporate, restructuring costs primarily within the USG segment, and purchase accounting adjustments related to the Phenix & Altanova acquisitions, partially offset by the final settlement from the sale of the Doble Watertown facility.

   
   

ESCO TECHNOLOGIES INC. AND SUBSIDIARIES
Condensed Business Segment Information (Unaudited)
(Dollars in thousands)
				GAAP						As Adjusted
				Q4 2022			Q4 2021			Q4 2022			Q4 2021
Net Sales
	Aerospace & Defense		$	103,742			80,105			103,742			80,105
	USG			83,490			61,107			83,490			61,107
	Test			69,266			64,266			69,266			64,266
		Totals	$	256,498			205,478			256,498			205,478
EBIT
	Aerospace & Defense		$	23,310			14,557			23,590			14,657
	USG			19,764			13,264			19,813			14,874
	Test			11,779			9,855			11,779			9,855
	Corporate			(12,658	)		(11,835	)		(12,428	)		(11,181	)
		Consolidated EBIT		42,195			25,841			42,754			28,205
		Less: Interest expense		(1,767	)		(802	)		(1,767	)		(802	)
		Less: Income tax expense		(9,388	)		(4,674	)		(9,517	)		(5,218	)
		Net earnings	$	31,040			20,365			31,470			22,185
Note 1: Adjusted net earnings of $31.5 million in Q4 2022 exclude $0.4 million (or $0.02 per share) of after-tax severance charges at VACCO and NRG, and Corporate management transition costs.
Note 2: Adjusted net earnings of $22.2 million in Q4 2021 exclude $1.8 million (or $0.07 per share) of after-tax charges mainly consisting of purchase accounting adjustments related to the Phenix & Altanova acquisitions, and acquisition costs at Corporate.
EBITDA Reconciliation to Net earnings:										Adjusted			Adjusted
				Q4 2022			Q4 2021			Q4 2022			Q4 2021
Consolidated EBITDA			$	54,291			37,631			54,850			39,995
Less: Depr & Amort				(12,096	)		(11,790	)		(12,096	)		(11,790	)
Consolidated EBIT				42,195			25,841			42,754			28,205
Less: Interest expense				(1,767	)		(802	)		(1,767	)		(802	)
Less: Income tax expense				(9,388	)		(4,674	)		(9,517	)		(5,218	)
Net earnings			$	31,040			20,365			31,470			22,185

   
   

ESCO TECHNOLOGIES INC. AND SUBSIDIARIES
Condensed Business Segment Information (Unaudited)
(Dollars in thousands)
				GAAP						As Adjusted
				FY 2022			FY 2021			FY 2022			FY 2021
Net Sales
	Aerospace & Defense		$	351,413			314,824			351,413			314,824
	USG			278,367			202,908			278,367			202,908
	Test			227,722			197,708			227,722			197,708
		Totals	$	857,502			715,440			857,502			715,440
EBIT
	Aerospace & Defense		$	68,352			56,536			68,967			57,021
	USG			57,604			40,948			58,120			42,427
	Test			32,592			27,636			32,592			27,636
	Corporate			(47,262	)		(42,194	)		(46,727	)		(38,167	)
		Consolidated EBIT		111,286			82,926			112,952			88,917
		Less: Interest expense		(4,851	)		(2,255	)		(4,851	)		(2,255	)
		Less: Income tax		(24,115	)		(17,175	)		(24,499	)		(18,553	)
		Net earnings	$	82,320			63,496			83,602			68,109
Note 1: Adjusted net earnings of $83.6 million in FY 2022 exclude $1.3 million (or $0.05 per share) of after-tax charges associated with the Altanova & Neco acquisition inventory step-up charges, severance charges at VACCO and NRG, and Corporate acquisition and management transition costs.
Note 2: Adjusted net earnings of $68.1 million in FY 2021 exclude $4.6 million ($0.17 per share) of after-tax charges mainly consisting of management transition and acquisition costs at Corporate, restructuring costs primarily within the USG segment, and purchase accounting adjustments related to the Phenix & Altanova acquisitions, partially offset by the final settlement from the sale of the Doble Watertown facility.
EBITDA Reconciliation to Net earnings:										Adjusted			Adjusted
				FY 2022			FY 2021			FY 2022			FY 2021
Consolidated EBITDA			$	159,629			124,975			161,295			130,966
Less: Depr & Amort				(48,343	)		(42,049	)		(48,343	)		(42,049	)
Consolidated EBIT				111,286			82,926			112,952			88,917
Less: Interest expense				(4,851	)		(2,255	)		(4,851	)		(2,255	)
Less: Income tax expense				(24,115	)		(17,175	)		(24,499	)		(18,553	)
Net earnings			$	82,320			63,496			83,602			68,109

   
   

ESCO TECHNOLOGIES INC. AND SUBSIDIARIES
Condensed Consolidated Balance Sheets (Unaudited)
(Dollars in thousands)
				September 30, 2022		September 30, 2021
Assets
	Cash and cash equivalents		$	97,724		56,232
	Accounts receivable, net			164,645		146,341
	Contract assets			125,154		93,771
	Inventories			162,403		147,148
	Other current assets			22,696		22,662
		Total current assets		572,622		466,154
	Property, plant and equipment, net			155,973		154,265
	Intangible assets, net			394,464		409,250
	Goodwill			492,709		504,853
	Operating lease assets			29,150		31,846
	Other assets			9,538		10,977
			$	1,654,456		1,577,345
Liabilities and Shareholders' Equity
	Current maturities of long-term debt		$	20,000		20,000
	Accounts payable			78,746		56,669
	Contract liabilities			125,009		106,045
	Other current liabilities			94,374		92,281
		Total current liabilities		318,129		274,995
	Deferred tax liabilities			82,023		73,560
	Non-current operating lease liabilities			24,853		28,032
	Other liabilities			48,294		47,062
	Long-term debt			133,000		134,000
	Shareholders' equity			1,048,157		1,019,696
			$	1,654,456		1,577,345

   
   

ESCO TECHNOLOGIES INC. AND SUBSIDIARIES
Consolidated Statements of Cash Flows
(Dollars in thousands)
		Year Ended September 30, 2022			Year Ended September 30, 2021
Cash flows from operating activities:
Net earnings	$	82,320			63,496
Adjustments to reconcile net earnings to net cash
provided by operating activities:
Depreciation and amortization		48,343			42,049
Stock compensation expense		7,320			6,914
Changes in assets and liabilities		(11,654	)		15,671
Gain on sale of building and land		0			(1,950	)
Effect of deferred taxes		8,946			(3,041	)
Net cash provided by operating activities		135,275			123,139
Cash flows from investing activities:
Acquisition of business, net of cash acquired		(10,906	)		(168,903	)
Capital expenditures		(32,101	)		(26,705	)
Additions to capitalized software		(12,912	)		(8,783	)
Proceeds from sale of building and land		0			1,950
Net cash used by investing activities		(55,919	)		(202,441	)
Cash flows from financing activities:
Proceeds from long-term debt		116,000			216,000
Principal payments on long-term debt and short-term borrowings		(117,000	)		(124,368	)
Dividends paid		(8,268	)		(8,336	)
Purchases of common stock into treasury		(19,878	)		0
Other		(2,976	)		(1,823	)
Net cash (used) provided by financing activities		(32,122	)		81,473
Effect of exchange rate changes on cash and cash equivalents		(5,742	)		1,501
Net increase in cash and cash equivalents		41,492			3,672
Cash and cash equivalents, beginning of period		56,232			52,560
Cash and cash equivalents, end of period	$	97,724			56,232

   
   

ESCO TECHNOLOGIES INC. AND SUBSIDIARIES
Other Selected Financial Data (Unaudited)
(Dollars in thousands)
Backlog And Entered Orders - Q4 2022				Aerospace & Defense			USG			Test			Total
	Beginning Backlog - 7/1/22		$	414,521			123,850			168,429			706,800
	Entered Orders			97,490			87,796			59,434			244,720
	Sales			(103,742	)		(83,490	)		(69,266	)		(256,498	)
	Ending Backlog - 9/30/22		$	408,269			128,156			158,597			695,022
Backlog And Entered Orders - FY 2022				Aerospace & Defense			USG			Test			Total
	Beginning Backlog - 10/1/21		$	367,216			91,631			133,176			592,023
	Entered Orders			392,466			314,892			253,143			960,501
	Sales			(351,413	)		(278,367	)		(227,722	)		(857,502	)
	Ending Backlog - 9/30/22		$	408,269			128,156			158,597			695,022

   
   

   

ESCO TECHNOLOGIES INC. AND SUBSIDIARIES
Reconciliation of Non-GAAP Financial Measures (Unaudited)
EPS – Adjusted Basis Reconciliation – Q4 2022
	EPS – GAAP Basis – Q4 2022	$	1.19
	Adjustments (defined below)		0.02
	EPS – As Adjusted Basis – Q4 2022	$	1.21
	Adjustments exclude $0.02 per share consisting of after-tax severance charges
	at VACCO and NRG and Corporate management transition costs.
	The $0.02 of EPS adjustments per share consists of $0.6 million of pre-tax charges
	offset by $0.2 million of tax benefit for net impact of $0.4 million.
EPS – Adjusted Basis Reconciliation – FY 2022
	EPS – GAAP Basis – FY 2022	$	3.16
	Adjustments (defined below)		0.05
	EPS – As Adjusted Basis – FY 2022	$	3.21
	Adjustments exclude $0.05 per share consisting of Altanova & Neco acquisition inventory
	step-up charges, severance charges at VACCO and NRG, Corporate acquisition costs and
	management transition costs.
	The $0.05 of EPS adjustments per share consists of $1.7 million of pre-tax charges
	offset by $0.4 million of tax benefit for net impact of $1.3 million
EPS – Adjusted Basis Reconciliation – Q4 2021
	EPS GAAP Basis – Q4 2021	$	0.78
	Adjustments (defined below)		0.07
	EPS – As Adjusted Basis – Q4 2021	$	0.85
	Adjustments exclude $0.07 per share consisting of purchase accounting adjustments,
	acquisition costs at Corporate, and restructuring costs primarily within the USG segment.
	The $0.07 of EPS adjustments per share consists of $2.3 million of pre-tax charges
	offset by $0.5 million of tax benefit for net impact of $1.8 million.
EPS – Adjusted Basis Reconciliation – FY 2021
	EPS – GAAP Basis – FY 2021	$	2.42
	Adjustments (defined below)		0.17
	EPS – As Adjusted Basis – FY 2021	$	2.59
	Adjustments exclude $0.17 per share consisting of management transition and acquisition
	costs, restructuring costs primarily within the USG segment, and purchase accounting
	adjustments partially offset by the settlement from sale of Doble Watertown facility.
	The $0.17 of EPS adjustments per share consists of $6.0 million of pre-tax charges
	offset by $1.4 million of tax benefit for net impact of $4.6 million.

   
   
SOURCE ESCO Technologies Inc.
Kate Lowrey, Vice President of Investor Relations, (314) 213-7277

FAQ

What were ESCO Technologies' Q4 2022 earnings results?

ESCO reported Q4 2022 GAAP EPS of $1.19, a 53% increase from Q4 2021.

How much did ESCO's sales increase in FY 2022?

FY 2022 sales increased by 20% to reach $858 million.

What is the forecast for ESCO's Adjusted EPS in 2023?

ESCO projects Adjusted EPS to increase by 7.5% to 12%, in the range of $3.45 to $3.60 per share.

What is the significance of ESCO's year-end backlog for FY 2022?

The year-end backlog reached a record $695 million, indicating strong demand and order momentum.

When will ESCO's new CEO officially take over?

Bryan Sayler will assume the role of CEO on January 1, 2023.